Author

Umesh Datta Gupta

Scientist G, NJIL&OMD , Agra -282004 - Cited by 3,431 - Tuberculosis and Leprosy

Biography

I am Umesh Datta Gupta, belonging to Department of Animal Experimentation, National JALMA Institute for Leprosy and Other Mycobacterial Diseases, Agra. Interested in the field of Bioenergetics, Mitochondria.
Title
Cited by
Year
Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009–15
E Cambau, P Saunderson, M Matsuoka, ST Cole, M Kai, P Suffys, ...Clinical Microbiology and Infection 24 (12), 5-1310, 2018201
130
2018
MicroRNA 17‐5p regulates autophagy in Mycobacterium tuberculosis‐infected macrophages by targeting Mcl‐1 and STAT3
R Kumar, SK Sahu, M Kumar, K Jana, P Gupta, UD Gupta, M Kundu, ...Cellular microbiology 18 (5), 679-691, 2016201
110
2016
Animal models of tuberculosis: Lesson learnt
AK Singh, UD GuptaThe Indian journal of medical research 147 (5), 456, 2018201
75
2018
Challenges beyond elimination in leprosy
F Naaz, PS Mohanty, AK Bansal, D Kumar, UD GuptaThe International Journal of Mycobacteriology 6 (3), 222-228, 2017201
70
2017
Development and characterization of spray-dried porous nanoaggregates for pulmonary delivery of anti-tubercular drugs
R Kaur, T Garg, B Malik, UD Gupta, P Gupta, G Rath, AK GoyalDrug delivery 23 (3), 872-877, 2016201
68
2016
Next generation sequencing and its applications
AK Gupta, UD GuptaAnimal biotechnology, 395-421, 2020202
58
2020
Whole genome sequencing of Mycobacterium tuberculosis clinical isolates from India reveals genetic heterogeneity and region-specific variations that might affect drug …
J Advani, R Verma, O Chatterjee, PK Pachouri, P Upadhyay, R Singh, ...Frontiers in microbiology 10, 309, 2019201
44
2019
Preparation and preclinical evaluation of inhalable particles containing rapamycin and anti-tuberculosis agents for induction of autophagy
A Gupta, D Sharma, J Meena, S Pandya, M Sachan, S Kumar, K Singh, ...Pharmaceutical research 33, 1899-1912, 2016201
38
2016
WHO surveillance network of antimicrobial resistance in leprosy. Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO …
E Cambau, P Saunderson, M Matsuoka, ST Cole, M Kai, P Suffys, ...Clin Microbiol Infect 24 (12), 1305-1310, 2018201
29
2018
Inhalable liposomes of Glycyrrhiza glabra extract for use in tuberculosis: formulation, in vitro characterization, in vivo lung deposition, and in vivo pharmacodynamic studies
V Viswanathan, R Pharande, A Bannalikar, P Gupta, U Gupta, A MukneDrug development and industrial pharmacy 45 (1), 11-20, 2019201
28
2019
Chemotherapeutic evaluation of guar gum coated chitosan nanoparticle against experimental tuberculosis
AK Goyal, T Garg, G Rath, UD Gupta, P GuptaJournal of biomedical nanotechnology 12 (3), 450-463, 2016201
25
2016
Tuberculosis preventive treatment: the next chapter of tuberculosis elimination in India
PK Moonan, SA Nair, R Agarwal, VK Chadha, PK Dewan, UD Gupta, ...BMJ global health 3 (5), e001135, 2018201
21
2018
Sustained expression of DevR/DosR during long-term hypoxic culture of Mycobacterium tuberculosis
P Kumari, K Sikri, K Kaur, UD Gupta, JS TyagiTuberculosis 106, 33-37, 2017201
15
2017
The α10 helix of DevR, the Mycobacterium tuberculosis dormancy response regulator, regulates its DNA binding and activity
A Vashist, D Prithvi Raj, UD Gupta, R Bhat, JS TyagiThe FEBS journal 283 (7), 1286-1299, 2016201
15
2016
Inhalable particles for “pincer therapeutics” targeting nitazoxanide as bactericidal and host-directed agent to macrophages in a mouse model of tuberculosis
A Gupta, J Meena, D Sharma, P Gupta, UD Gupta, S Kumar, S Sharma, ...Molecular Pharmaceutics 13 (9), 3247-3255, 2016201
14
2016